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acid based cream in the prevention of radiation induced skin 
toxicity (RIST). 
 
Material and Methods: Patients undergoing breast irradiation 
after conservative surgery for breast cancer were considered 
for the study. The patients were randomly assigned to use T-
lysyal (repalysyal, a thymine-lysine-hyaluronic acid based 
cream) vs. patients using a moisturizing cream. The patients 
were stratified for age, breast size, and phototype. Radiation 
therapy was delivered with 3D conformal radiation therapy, 
with 20 fraction of 2.25 Gy (concomitant boost dose 2.5 Gy) 
on the residual breast for a total dose of 45 Gy in 4 weeks (50 
Gy boost dose to the tumoral bed). The appearance of any 
grade of skin toxicity was the endpoint of our study. RIST was 
assessed weekly from the beginning of treatment and graded 
according to the RTOG acute skin toxicity scale. 
 
Results: Fifty two consecutive patients undergoing radiation 
therapy after breast conserving surgery for breast cancer 
were randomized to have the skin treated with 2 daily 
application of Repalysyal or a simple moisturizing cream. 
Median age of the patients was 54. At the end of treatment 
(4 weeks) 15/26 patients in the Repalysyal group vs. 26/26 
patients in the control group had any grade of skin toxicity 
(p=0.0001). Moreover, among patients that developed skin 
toxicity, 3/15 vs. 18/26 developed G2 toxicity in Repalysial 
and control group, respectively (0.0036). 
 
Conclusion: Repalysyal ameliorates the acute skin toxicity 
profile of patients undergoing radiation therapy after 
conservative surgery for breast cancer. 
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Purpose or Objective: Many authors suggest, when the 
patients is suitable, the complete reconstruction of the 
breast which has undergone radiation by autologous tissue, 
discouraging prosthetic placing because of the high level of 
post-radiotherapic complications observed. The aim of this 
study is the assessment of radiation-induced outcomes in 
women with breast cancer who have been subjected to 
radiotherapy after reconstruction. 
 
Material and Methods: Between January 2011 and March 
2013 we chose 17 patients, median age of 45 years; 15 of 
these had undergone a radical mastectomy and 2 a 
quadrantectomy. During the mastectomy 7 patients were 
given an immediate prothesis, 9 underwent reconstruction by 
lipofilling by way of classical breast expander and following 
prothesis , 1 quadrantectomy and breast remodelling by 
lipofilling. All the patients received adjuvant chemiotherapy 
and/or hormonotherapy, conformational radiotherapy on the 
thoracic wall or residue breast(total dose of 50 Gy) and local 
prophilactic therapy so as to minimize the radiation-induced 
adverse effects. All patients have gone thruogh a clinical-
instrumental follow-up over an median time of 12 months and 
an assessment of cutaneous toxicity according to the SOMA-
LENT scale. 
 
Results: It was observed in 2 of the cases capsular 
contracture of the prothesis of high grade which needed 
further replacing and apperance of cutaneous ulcers (grade 
2) in 1 patient ;in the remaining cases of prosthetic 
reconstruction erythema and edema were found (grade2). A 
tolerable erythema was observed in the patients with 
expander and simultaneous lipofilling without late fibrosis. 
No complications were found in the patients with rimodelling 
by lipofilling post quadrantectomy, with conservation of the 
shape and simmetry of the breast. 
Conclusion: The grafting of the autologous fat, high in 
stamina cells, represents an alternative technique in breast 
reconstruction with complete functional recovery of the 
tissue , so improving the the surrounding tissue and therefore 
the capacity to heal in the irradiated tissues. The use of 
lipofilling is becoming an ever increasing importance as a 
coadjuvant in the breast reconstruction and avoids 
radiotherapy-induced complications. This gives notable 
psychophysical benefits and improves the quality of life in 
the patients. 
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Purpose or Objective: Whole breast irradiation (WBI) is the 
gold standard after breast conserving surgery (BCS), followed 
by an additional boost when negative prognostic factors are 
present. WBI can be administered with hypofractionated 
schedules, on the basis of the relatively low α/β ratio for 
breast cancer (BC). The aim of our study was to investigate 
the effects of an additional hypofractionated boost (HB) in 
terms of acute and short-term late skin and subcutaneous 
tissue toxicity. 
 
Material and Methods: Between March 2014 and April 2015 
156 women, median age 62 years (range 34-88) with early BC 
(pT1-pT2, N0-N1) underwent hypofractionated RT (single 
dose of 2.65 Gy to 42.4 Gy in 16 fractions over 3 weeks) ± HB 
(single dose 2.65 Gy to 10.6 Gy in 4 fractions). The study 
enrolled 71 patients (pts) without HB (45.5%) and 85 with HB 
(54.5%). The additional HB was delivered if risk factors such 
as young age, positive nodes, negative hormonal receptors, 
high Ki67 or HER2/neu overexpression were present. 
According to the risk of relapse chemotherapy (CT) and/or 
Hormonal Therapy (HT) and/or Trastuzumab were 
administered. For the analysis of the acute and late toxicity 
CTCAE 4.03 scale was used. Pts had physical examination at 
5th, 10th, 16th and 20th day of RT and then 1 and 6 months 
after the end of treatment. Statistical analysis was carried 
out by the Chi-square test and the Mann–Whitney's U-test was 
used to compare continuous variables. 
 
Results: HB group characteristics were: younger age (median 
56 vs 67), longer time gap between surgery and RT (median 
time 20 weeks vs 16), more advance stage (43.6 % stage II vs 
14.1%), CT (37 pts vs 2), HT (71 pts vs 48). Hypofractionated 
RT was well tolerated with or without HB and no G3 overall 
toxicity was documented. HB did not contribute to major skin 
toxicity; at the end of the treatment only 14 cases had G2 
dermatitis vs 5 which did not receive HB (p = 0.073).One 
month after RT HB and CT significantly impacted upon edema 
occurrence: 15.5% HB group vs 1.5% no HB (p = 0.008) and 
18.4 % CT group vs 6.2% no CT (p = 0.016). Furthermore, CT 
emerged as a risk factor for hyperpigmentation 6 months 
after RT: 37.0% vs 10.4% (p = 0.003). Attached Table 
summarizes the toxicity time-related events. 
